These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

803 related items for PubMed ID: 32149781

  • 1. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT, Chan WK, Wong GL, Chan AW, Nik Mustapha NR, Chan SL, Chong CC, Mahadeva S, Shu SS, Lai PB, Chan HL, Wong VW.
    Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.
    Lee HL, Bae SH, Lee J, Sung PS, Lee SW, Jang JW, Lee J, Choi JY, Han NI, Yoon SK.
    Cancer Control; 2021 Jun; 28():10732748211039758. PubMed ID: 34569320
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
    Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.
    Ann Intern Med; 2007 May 01; 146(9):649-56. PubMed ID: 17470833
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
    Lin BZ, Lin TJ, Lin CL, Liao LY, Chang TA, Lu BJ, Chen KY.
    J Chin Med Assoc; 2021 Jun 01; 84(6):606-613. PubMed ID: 33871391
    [Abstract] [Full Text] [Related]

  • 9. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ, Kwack MS, Jang ES, You SJ, Lee JH, Kim YJ, Yoon JH, Lee HS.
    Digestion; 2011 Jun 01; 84 Suppl 1():17-22. PubMed ID: 22156481
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.
    Kwon OS, Jung YK, Bae KS, Kim JH, Kim SG, Kim YS, Lee JI, Lee JW, Kim YS.
    Alcohol; 2012 Sep 01; 46(6):537-41. PubMed ID: 22572059
    [Abstract] [Full Text] [Related]

  • 14. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study.
    Prabhakar T, Kaushal K, Prasad M, Gupta E, Sood A, Jain AK, Shukla A, Goel A, Duseja A, Saraya A, Shah S, Kumar G, Sarin SK.
    Hepatol Int; 2023 Jun 01; 17(3):745-752. PubMed ID: 36940070
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-Gomez M.
    Gastroenterology; 2018 Aug 01; 155(2):443-457.e17. PubMed ID: 29733831
    [Abstract] [Full Text] [Related]

  • 17. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM, Castanhole-Nunes MMU, Pavarino ÉC, da Silva RF, da Silva RCMA, Maria Goloni-Bertollo E.
    Asian Pac J Cancer Prev; 2018 Oct 26; 19(10):2795-2802. PubMed ID: 30360608
    [Abstract] [Full Text] [Related]

  • 18. Radiologic Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Suppressed Chronic Hepatitis B.
    Cho H, Chang Y, Lee JH, Cho YY, Nam JY, Lee YB, Lee DH, Cho EJ, Yu SJ, Kim YJ, Lee JM, Yoon JH.
    J Clin Gastroenterol; 2020 Aug 26; 54(7):633-641. PubMed ID: 31033805
    [Abstract] [Full Text] [Related]

  • 19. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
    Omata M, Ashcavai M, Liew CT, Peters RL.
    Gastroenterology; 1979 Feb 26; 76(2):279-87. PubMed ID: 215488
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.